Domestic technology for placenta injectable near commercialized.

Published: 2004-10-29 06:56:00

Updated: 2004-10-29 06:56:00

It is near ready for the human placenta to be commercially available in Korea after due technology success in isolating and purifying the bio active substances from crude human placenta.

Bio R&Ds (President: Choi Moon-soo) took a signing ceremony of the technology licensing agreement with Dong...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK